Can vaccinated people still spread COVID-19? How long does immunity last? Here s what science knows now bemidjipioneer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bemidjipioneer.com Daily Mail and Mail on Sunday newspapers.
Five years later: CAR T therapy shows long-lasting remissions in non-Hodgkin lymphomas Findings represent the longest follow-up data to date for a personalized cellular therapy approved by the FDA for the treatment of aggressive lymphomas.
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five years after receiving the chimeric antigen receptor (CAR) T cell therapy Kymriah™, researchers in Penn’s Abramson Cancer Center reported in the
Medicine. The findings represent the longest follow-up, published data to date for CAR T cell therapies approved by the U.S. Food and Drug Administration for the treatment of relapsed or refractory large B-cell lymphomas.
A Penn study is among many now underway to answer these questions. None of which is reason to hesitate in getting the vaccines, which are safe and remain our best hope of curbing the pandemic.
WHYY
By
(Tembinkosi Sikupela / Unsplash)
Heather Burris remembers growing up in a small, predominantly Black suburb on the north end of Hartford, Connecticut. Burris would go on to pursue a career in medicine, but she said her early experiences as a white girl in her hometown had an immense impact on her life’s trajectory.
“Within my small micro-community, I was a minority and was able to see the world in more of a racialized lens,” said Dr. Burris. “And so when I came into medicine [and] I would see the sort of over-representation of Black infants in the neonatal intensive care unit, I started asking questions why.”